Tooth extraction.
Conditions
Interventions
Intervention 1: First intervention group: Patients that receiving a single dose of celecoxib 200 mg capsules. Intervention 2: second intervention group: Patients receiving a single dose of Mefenamic a
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
14 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients over 14 years and of any sex who do not have a serious systemic disease and are classified in class 1 or 2 of The American Society of Anesthesiologists (ASA) will be included in this study.
Exclusion criteria
Exclusion criteria: Patients who referred for tooth extraction due to periodontal support problem will not be included in the study. Patients with symptoms of infection such as swelling, fever, pus discharge, and decreased mouth opening will also not be included in the study. Patients who need analgesics for any reason other than toothache will not be included in the study. Patients who have a history of taking any painkillers up to 12 hours before tooth extraction will not be included in this study. Patients with systemic physical or mental illness or at risk for infectious endocarditis, coagulation problems, local and systemic infections, known allergies to celecoxib or mefenamic acid, a history of asthma, or drug or alcohol addiction will not be included in this study. Patients who require severe surgical intervention to extract a tooth will not be included in this study. celecoxib is contraindicated in patients with heart problems. Therefore, patients with heart disease will not participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score in Visual Analogue Scale score questionnaire. Timepoint: Measure the amount of pain in one, three and six hours after tooth extraction. Method of measurement: Visual Analogue Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmin Samimi
Shahre-kord University of Medical Sciences
Outcome results
None listed